Our findings reveal that SH3BP5 is selectively overexpressed in ABC-DLBCL relative to GCB-DLBCL and functions as an independent prognostic marker for poor survival, linking mitochondrial function with clinical outcomes. The gene discussed is SH3BP5; the disease is aneurysmal bone cyst.